Exagen Inc. (XGN) Insider Trading

Last 12 months

Insiders sold $522k and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in Nov 2024.

Net open-market

−$522k

0 buys · 5 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

Nov 2024

Nov 15, 2024

Get an email when XGN's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 19	Jorey Chernett Large holder	Bought	14,000	$7.46	$104k	0.5%	Form 4
Oct 16	John Aballi President and CEO	SoldNo plan	34,294	$7.87	$270k	3.9%	Form 4
Sep 1	Jeffrey G. Black Chief Financial Officer	SoldNo plan	20,614	$7.22	$149k	6.0%	Form 4
Mar 3	John Aballi President and CEO	SoldNo plan	15,698	$3.62	$57k	2.1%	Form 4
Feb 24	John Aballi President and CEO	SoldNo plan	11,430	$3.61	$41k	1.5%	Form 4
Feb 24	Jeffrey G. Black Chief Financial Officer	SoldNo plan	1,584	$3.61	$6k	0.6%	Form 4
Oct 16, 2025	John Aballi President and CEO	SoldNo plan	31,787	$11.82	$376k	4.0%	Form 4
Sep 2, 2025	Jeffrey G. Black Chief Financial Officer	SoldNo plan	20,466	$9.79	$200k	7.1%	Form 4
Mar 25, 2025	Nmsic Co-Investment Fund, L.p. Large holder	SoldNo plan	350,000	$3.30	$1.16M	17%	Form 4
Nov 20, 2024	Sun Mountain Capital Partners LLC Large holder	SoldNo plan	200,000	$3.30	$660k	8.7%	Form 4
Nov 15, 2024	Jeffrey G. Black Chief Financial Officer	Bought	22,298	$2.98	$66k	8.8%	Form 4
Nov 14, 2024	John Aballi President and CEO	Bought	24,305	$2.81	$68k	3.7%	Form 4

Oct 19
Jorey Chernett
Large holder · bought 14,000 at $7.46
$104k
0.5% of stake
Oct 16No plan
John Aballi
President and CEO · sold 34,294 at $7.87
$270k
3.9% of stake
Sep 1No plan
Jeffrey G. Black
Chief Financial Officer · sold 20,614 at $7.22
$149k
6.0% of stake
Mar 3No plan
John Aballi
President and CEO · sold 15,698 at $3.62
$57k
2.1% of stake
Feb 24No plan
John Aballi
President and CEO · sold 11,430 at $3.61
$41k
1.5% of stake
Feb 24No plan
Jeffrey G. Black
Chief Financial Officer · sold 1,584 at $3.61
$6k
0.6% of stake
Oct 16, 2025No plan
John Aballi
President and CEO · sold 31,787 at $11.82
$376k
4.0% of stake
Sep 2, 2025No plan
Jeffrey G. Black
Chief Financial Officer · sold 20,466 at $9.79
$200k
7.1% of stake
Mar 25, 2025No plan
Nmsic Co-Investment Fund, L.p.
Large holder · sold 350,000 at $3.30
$1.16M
17% of stake
Nov 20, 2024No plan
Sun Mountain Capital Partners LLC
Large holder · sold 200,000 at $3.30
$660k
8.7% of stake
Nov 15, 2024
Jeffrey G. Black
Chief Financial Officer · bought 22,298 at $2.98
$66k
8.8% of stake
Nov 14, 2024
John Aballi
President and CEO · bought 24,305 at $2.81
$68k
3.7% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch XGN, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Medical Laboratories

BNRBurning Rock Biotech Ltd

PSNLPersonalis Inc.

BDSXBiodesix Inc.

CFORCapForce Inc.

AMSAmerican Shared Hospital Services

PMDIPsychemedics Corp.

GRALGrail, Inc.

FLGTFulgent Genetics Inc.

Spot a number that looks wrong? Check it in XGN's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing XGN

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.